Genitourinary syndrome of menopause (GSM) is a common health problem faced by postmenopausal women. However, lack of knowledge about this syndrome prompts many women into regarding it as a normal condition of natural aging. Additionally, quite a few healthcare professionals do not proactively screen and pay attention to this problem, rendering GSM underdiagnosed and undertreated, leading to recurrent urinary tract infections affecting intimate relationships with their partners. Depending on the severity of symptoms, treatment options of GSM include vaginal moisturizers, lubricants, vaginal estrogen creams, and systemic estrogen replacement therapy. Recently, laser therapies and the use of vaginal probiotics have gained popularity as treatment options. However, as the efficacy of these novel therapies remains in need of further clinical research and evidence, shared decision-making should be applied when discussing treatment with patients. Aiming at enhancing GSM diagnosis and treatment to improve the quality of life for postmenopausal women, this article examines in a comprehensive manner the clinical manifestations, risk factors, diagnosis methods, and pharmacologic treatments, and non-pharmacologic interventions for GSM.